The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 08, 2012
Filed:
Feb. 06, 2008
Gordana Atallah, Emeryville, CA (US);
Sarah Bartulis, Emeryville, CA (US);
Matthew Burger, Emeryville, CA (US);
Hanne Merritt, Emeryville, CA (US);
Simon NG, Emeryville, CA (US);
Zhi-jie NI, Emeryville, CA (US);
Sabina Pecchi, Emeryville, CA (US);
Keith B. Pfister, Emeryville, CA (US);
Aaron Smith, Emeryville, CA (US);
Charles Voliva, Emeryville, CA (US);
Allan Wagman, Emeryville, CA (US);
Yanchen Zhang, Emeryville, CA (US);
Gordana Atallah, Emeryville, CA (US);
Sarah Bartulis, Emeryville, CA (US);
Matthew Burger, Emeryville, CA (US);
Hanne Merritt, Emeryville, CA (US);
Simon Ng, Emeryville, CA (US);
Zhi-Jie Ni, Emeryville, CA (US);
Sabina Pecchi, Emeryville, CA (US);
Keith B. Pfister, Emeryville, CA (US);
Aaron Smith, Emeryville, CA (US);
Charles Voliva, Emeryville, CA (US);
Allan Wagman, Emeryville, CA (US);
Yanchen Zhang, Emeryville, CA (US);
Other;
Abstract
Phosphatidylinositol (PI) 3-kinase inhibitor compounds, their pharmaceutically acceptable salts, and prodrugs thereof; compositions of the new compounds, either alone or in combination with at least one additional therapeutic agent, with a pharmaceutically acceptable carrier; and uses of the new compounds, either alone or in combination with at least one additional therapeutic agent, in the prophylaxis or treatment of diseases characterized by the abnormal activity of growth factors, protein serine/threonine kinases, and phospholipid kinases, including proliferative diseases, inflammatory and obstructive airways diseases, allergic conditions, autoimmune and cardiovascular diseases.